SEOUL, Jan. 22 (Yonhap) -- SK bioscience Co., a biopharmaceutical arm of South Korea's SK Group, said Thursday it will accelerate the development of a Zaire Ebola virus vaccine with funding from the ...
Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports ...
If licensed and in the event of an influenza pandemic, Moderna will allocate 20% of its H5 pandemic vaccine manufacturing capacity for timely supply to low- and middle-income countries at affordable ...
Global health organisation Coalition for Epidemic Preparedness Innovations (CEPI) will give roughly $60m to Moderna and two other groups to accelerate the development of shots against Ebola Bundibugyo ...
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna’s investigational vaccine against ...
The Coalition for Epidemic Preparedness Innovations (CEPI) and CDMO Samsung Biologics formed a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results